RE:RE:RE:RE:RE:Echelon Partners Yes, I am likely being too conservative.
The first few weeks may have been something like 20,40,60 scripts in weeks 1-3.
Now, with insurance coming on board and 250 clinics looking in to the drug, we should see further acceleration. Therefore, we could see a big jump in scripts written.
The funny things is if they report 1000 pts, that is around an EPS of 68 cents per share for these pts over a 12 month period (factoring out Egrifta paying for expenses).
That would make the current share price still a joke as at a minimum, a PE of 40 would need to be considered with this growth rate.
Meanwhile, it looks like Europe has the possibility of adding $8-10 or so to the SP down the line.
This could be a rather interesting summer for TH’s share price if the pace of script keeps accelerating.
bfw
palinc2000 wrote: Accelarating I think (I hope)should mean more than 500!
One thousand or there about with ignite the SP